On January 16, 2024, ASTHO and the Satcher Health Leadership Institute (SHLI) at Morehouse School of Medicine unveiled the latest cohort of 15 mid-to-senior level governmental public health ...
On December 11, 2023, ASTHO announced the release of the 2024 Legislative Prospectus Series, which provides an overview of anticipated policies and potential evidence-based interventions for ...
On October 31, 2023 ASTHO announced the approval of one new and four updated health policy statements.
Readout of CDC/ASTHO/CSTE/APHL Call Regarding Avian Influenza Preparedness Arlington, VA—On Friday, Nirav D. Shah, CDC’s Principal Deputy Director, Dr. Demetre Daskalakis, Director of CDC’s National ...
On Feb. 26, 2024, ASTHO's CMO issued a statement in response to several measles outbreaks currently occurring in the United States.
On Sept. 22, 2021, ASTHO announced the launch of Public Health Review Morning Edition, a daily on-demand newscast that covers the latest trends, news, and breakthroughs in public health throughout ...
On May 8, 2023, ASTHO announced the organization's recognition as a Healthy People 2030 Champion by the Office of Disease Prevention and Health Promotion.
On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug ...
On March 23, 2023, ASTHO President Anne Zink testified before the U.S. House of Representatives Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
ASTHO Applauds Administration's Commitment to Combat the Opioid Epidemic ARLINGTON, VA—Michael Fraser, executive director of ASTHO, issued the following response to HHS Secretary Tom Price’s ...